Celldex Therapeutics CLDX Business Segments — Facility Expense

Similar metrics at other companies

QURESingle Reportable — Facility Expenses

$1.44M-15.7%

SESSingle Reportable — Costs Of Facility

$1.42M-8.5%

URGSingle Reportable — Accretion Expense

$429K+54.9%

URGSingle Reportable — Exploration Expense

$2.28M+118%

OCULSingle Reportable — Facilities Expense

$2.27M+36.4%

PKBKSingle Reportable — Noninterest Expense

$6.92M+3.6%

FAQ

What is Celldex Therapeutics's business segments — facility expense?

Celldex Therapeutics (CLDX) reported business segments — facility expense of $1.18M in Q2 2026.

How has Celldex Therapeutics's business segments — facility expense changed year-over-year?

Celldex Therapeutics's business segments — facility expense decreased by 15.7% year-over-year, from $1.4M to $1.18M.

What does business segments — facility expense mean?

This metric represents the overhead costs associated with maintaining the physical infrastructure, such as laboratories and office space, required to support the primary business segment. It includes rent, utilities, and maintenance expenses necessary for ongoing operations. Tracking this metric provides insight into the fixed cost structure and operational footprint of the company's research activities.